yttrium 90 Y ibritumomab tiuxetan

yttrium 90 Y ibritumomab tiuxetan, a chelate of yttrium 90 and the immunoconjugate ibritumomab tiuxetan, used in the treatment of non-Hodgkin’s lymphoma. It is administered intravenously.